[Cerebral embolism and atrial fibrillation]

Yoshikazu Uesaka1

  • 1Department of Neurology, Toranomon Hospital, Tokyo, Japan.

Insights

Warfarin anticoagulation for atrial fibrillation (Af) in Japan is often insufficient, and combining it with antiplatelets is harmful. New oral anticoagulants (NOACs) offer convenience and safety but require proper usage guidelines.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Context:

  • Atrial fibrillation (Af) is a primary cause of cerebral embolisms.
  • Warfarin anticoagulation is prevalent in Japan but often sub-therapeutic.
  • Concomitant use of warfarin and antiplatelets lacks evidence and poses risks.

Purpose:

  • To review the challenges of warfarin therapy in Af patients.
  • To evaluate the role and risks of antiplatelets in Af.
  • To discuss the advantages and uncertainties surrounding new oral anticoagulants (NOACs).

Summary:

  • Warfarin therapy for Af in Japan frequently shows insufficient anticoagulation intensity.
  • Evidence does not support the efficacy of antiplatelets for embolism prevention in Af.
  • Concomitant warfarin and antiplatelet use is potentially harmful, particularly concerning intracranial hemorrhage.
  • New oral anticoagulants (NOACs) present a more convenient and safer alternative, enabling broader application in lower-risk patients.
  • Optimal strategies for utilizing the different available NOACs remain to be clarified.

Impact:

  • Highlights the need for optimized anticoagulation strategies in Af.
  • Warns against the unproven and risky combination of warfarin and antiplatelets.
  • Suggests NOACs can expand anticoagulation therapy to broader patient populations.
  • Identifies a critical knowledge gap in the clinical application of NOACs.

Related Concept Videos

Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
Pulmonary Embolism I: Introduction01:19

Pulmonary Embolism I: Introduction

A blood clot, or thrombus, is a semi-solid mass composed of fibrin, platelets, and red blood cells. When it forms within a vessel, it can obstruct blood flow, known as thrombosis. If part of the clot detaches, it becomes an embolus that can travel and block distant vessels. When this occurs in the pulmonary arteries, it causes a condition known as pulmonary embolism (PE).Origin and ImpactMost often, the embolus originates from a thrombus in the deep veins of the lower limbs, a condition called...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Cerebral Edema ll: Pathophysiology01:22

Cerebral Edema ll: Pathophysiology

Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this barrier loses...
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias01:25

ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias

Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...